CALCIUM carbonateDRUG carriersHUMAN bodyBIOCOMPATIBILITYA drug carrier usually refers to a tool that can carry the effective ingredients of drugs into the human body. The drug-controlled release system prepared by a new drug carrier can allow the gradual release of the drug in the human...
We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some...
Naked RNAs are susceptible to nuclease degradation and they are too large, hydrophilic, and negatively charged to cross cellular membranes by themselves,6 which requires the use of delivery vectors. Following administration, vector-formulated RNAs are confronted with a series of barriers posed by the...
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your perso...
Thus, the aims of the present review were as follows: (1) to document and analyse local knowledge about the veterinary use of invertebrates and their derivative products in contemporary Spanish EVM; (2) to contribute to the transfer of part of the traditional knowledge to new generations; (3...
Hydroxyapatitecarbonate degraded frombioglass(BG) in the physiological environment can rapidly interact with surrounding normal bone tissue to promote new bone formation. However, the clinical use ofbioactive glassis limited and implants fail due to instability of the crystal phase boundaries in the glas...
the use of factors that inhibit the enzymatic activity of MIF; the use of compounds that inhibit the release of MIF from cellular sources in the body; and the use of nucleotide sequences derived from MIF coding, non-coding, and/or regulatory sequences to prevent or reduce MIF expression. ...
The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for ...
Some work has been performed on the coating of these coils to provide a surface with increase thrombogenicity and render it biologically active by enabling the release of cellular growth factors and the like (German Patent DE-A-19647280). Others have concentrated on the use of polymer systems ...
2. Methods of treating osteoporosis and other bone disorders involving calcium loss from the bones, or hypertension, or premenstrual syndrome by administering GLA (as above) in combination with calcium (as above). The invention also extends to the use of said GLA and calcium together or separatel...